Respiratory Dystress Syndrome. Hyaline membrane disease
Conditions
Interventions
Intervention 1: Advising Cursourf with 2.5 cc/kg slowly via neonatal trachea with vital sign control and cardiopulmonary monitoring. Intervention 2: Advising Bles 5 cc/kg rapidly via neonatal trachea
Treatment - Drugs
Advising Cursourf with 2.5 cc/kg slowly via neonatal trachea with vital sign control and cardiopulmonary monitoring
Advising Bles 5 cc/kg rapidly via neonatal trachea with vital sign control and cardiopulmonary monitoring
Sponsors
Vice Chancellor of Kerman University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: less than 34 weeks gestational age; Confirmed Respiratory Distress Syndrome Exclusion Criteria: Confirmed Sepsis; Congenital heart diseases; Pulmonary hemorrhage; Congenital Pneumonia
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Oxygenic Index. Timepoint: Before and 12 hours after intervention. Method of measurement: According ABG and ventilator indices.;Ventilation period. Timepoint: Before and 12 hours after intervention. Method of measurement: Neonates medical records.;NCPAP period. Timepoint: before and 12 hours after Intervention. Method of measurement: Neonates medical records.;Hospitalization time. Timepoint: After Intervention. Method of measurement: Neonates medical records. | — |
Secondary
| Measure | Time frame |
|---|---|
| Mortality rate. Timepoint: Before and 12 hours after intervention. Method of measurement: medical folder of neonates. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Zeinab Kheradmand
Kerman University of Medical Sciences
Outcome results
None listed